Skip to content
Saturday, October 10, 2026
Discover the latest trends in lifestyle, technology, and cu…

Social Media Content Creators Fueling Unofficial Market for Unlicensed Weight-Loss Drug

A shadow economy for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these accounts privately for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where groups with numerous of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users administering substances of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.

Service Reaction and Content Removal

Based on the social media company, the platform has taken down violative content and banned related hashtags and search suggestions. The company said it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Research also found communities with up to 9,000 members selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, populated with images of slimming results, positive reviews and detailed instructions for preparing or injecting at home.

After moments of joining one community, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Item Details and Costs

Within these groups, posts display black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A representative for Telegram said it actively monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet approved … may subject users to potentially significant medical dangers”.

About the author

Felicia Jones

Elena Hartwell is a freelance writer and lifestyle enthusiast with a passion for exploring modern trends and sharing actionable advice.

Modern Arena Focus

Type to search articles.